An initiative by hemp stakeholders has been successful in reversing a potential ban on the trading of certain cannabis stocks including CBD and hemp food companies by the German stock […]
Stakeholder pushback clears stocks for trading on German exchange Read More »
Paul Benhaim, CEO at Elixinol Global Ltd., is confirmed as among featured speakers at next year’s first Asian Hemp Summit in Nepal. The event is Feb. 1-2, 2019 at the
Benhaim is featured speaker at inaugural Asian Hemp Summit Read More »
Denver, Colorado-based Elixinol Global Limited today debuted on the OTCQX Best Market in the USA just ahead of anticipated changes in federal legislation that could supercharge the CBD sector. Elixinol,
Elixinol debuts on U.S. exchange as Farm Bill vote looms Read More »
An International Cannabis Policy Conference Dec. 7-9, 2018 in Vienna is the last opportunity for stakeholder input into crucial international regulations that will go to the United Nations next year.
Meetings in Vienna to sharpen global guidelines for cannabis, CBD Read More »
Despite significant institutional challenges, the European CBD market will see strong growth for those companies that can navigate the murky waters of EU regulation while managing growth in a fast
Euro CBD market will grow; look for some shakeout globally Read More »
Illinois is the latest state in the USA to set rules allowing for the farming and processing of industrial hemp. Under a law signed by Gov. Bruce Rauner earlier this
Illinois, with newest hemp program in USA, will allow CBD extraction Read More »
Australia-based Creso Pharma has inked an agreement with Pharmacare Europe to market and distribute its cannaQIX CBD product in the UK, the companies said in a release. The deal could
Creso Pharma in distribution deal with Pharmacare in UK Read More »
The Green Organic Dutchman Holdings Ltd. (TGOD) said it will buy 100% of HemPoland, maker of fast-moving CBD brand CannabiGold, in a deal that values the Elblag, Poland-based company at
Cash and stock deal for Polish hemp firm: $15.5 million Read More »
Insured patients in the USA would pay up to $200 per month for CBD-based drug Epidiolex under a recent pricing announcement from the maker, UK-based GW Pharmaceuticals. Epidiolex is the
GW Pharma releases pricing on newly approved CBD-drug Read More »
Jacek Kramarz, Chief of Sales at Poland’s blue-chip CBD maker HemPoland, will talk about his experiences with a fast-moving startup that’s quickly expanded distribution of its CannabiGold brand into 20
HT Summit will hear story of Polish CBD brand’s fast rise Read More »
